Effect of Orally Pregabalin Given Before Knee Joint Replacement on Reperfusion Injury Which Caused by Bandage

Trial Profile

Effect of Orally Pregabalin Given Before Knee Joint Replacement on Reperfusion Injury Which Caused by Bandage

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2018

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Reperfusion injury
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 09 Jul 2018 Planned End Date changed from 7 Jul 2018 to 30 Sep 2018.
    • 09 Jul 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Aug 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top